Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,832,000 | 5,369,000 | 4,831,000 | 3,324,000 | 5,018,000 |
| Marketable Securities | 302,000 | 885,000 | 1,107,000 | 1,258,000 | 911,000 |
| Receivables | 7,386,000 | 6,046,000 | 5,781,000 | 5,533,000 | 4,999,000 |
| Inventories | 4,024,000 | 3,193,000 | 2,890,000 | 3,035,000 | 2,334,000 |
| Other current assets | 0 | 70,000 | 982,000 | 0 | 0 |
| TOTAL | $19,544,000 | $15,563,000 | $15,591,000 | $13,150,000 | $13,262,000 |
| Non-Current Assets | |||||
| PPE Net | 8,251,000 | 7,688,000 | 7,421,000 | 7,615,000 | 6,848,000 |
| Investments And Advances | 1,318,000 | 1,520,000 | 1,079,000 | 1,540,000 | 1,169,000 |
| Intangibles | 32,792,000 | 32,501,000 | 33,666,000 | 38,013,000 | 39,244,000 |
| Other Non-Current Assets | 4,824,000 | 4,105,000 | 2,894,000 | 3,036,000 | 2,003,000 |
| TOTAL | $47,185,000 | $45,814,000 | $45,060,000 | $50,204,000 | $49,264,000 |
| Total Assets | $66,729,000 | $61,377,000 | $60,651,000 | $63,354,000 | $62,526,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,194,000 | 1,822,000 | 1,754,000 | 2,247,000 | 2,307,000 |
| Accounts payable and accrued liabilities | 15,785,000 | 13,987,000 | 12,841,000 | 11,641,000 | 10,486,000 |
| Other current liabilities | 1,009,000 | 759,000 | 533,000 | 1,145,000 | 1,083,000 |
| TOTAL | $20,307,000 | $18,117,000 | $16,292,000 | $16,383,000 | $15,256,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,505,000 | 15,730,000 | 17,359,000 | 15,560,000 | 14,501,000 |
| Other Non-Current Liabilities | 10,413,000 | 10,552,000 | 9,775,000 | 10,907,000 | 12,237,000 |
| TOTAL | $30,784,000 | $28,664,000 | $30,315,000 | $30,329,000 | $30,601,000 |
| Total Liabilities | $51,091,000 | $46,781,000 | $46,607,000 | $46,712,000 | $45,857,000 |
| Shareholders' Equity | |||||
| Common Shares | 328,000 | 328,000 | 317,000 | 317,000 | 316,000 |
| Retained earnings | 5,299,000 | 2,812,000 | 5,683,000 | 8,221,000 | 8,140,000 |
| Other shareholders' equity | 2,040,000 | 3,515,000 | 3,617,000 | 3,711,000 | 3,862,000 |
| TOTAL | $15,638,000 | $14,596,000 | $14,044,000 | $16,642,000 | $16,669,000 |
| Total Liabilities And Equity | $66,729,000 | $61,377,000 | $60,651,000 | $63,354,000 | $62,526,000 |